Literature DB >> 23758329

Classification accuracy of serum Apo A-I and S100B for the diagnosis of mild traumatic brain injury and prediction of abnormal initial head computed tomography scan.

Jeffrey J Bazarian1, Brian J Blyth, Hua He, Sohug Mookerjee, Courtney Jones, Karin Kiechle, Ryan Moynihan, Susan M Wojcik, William D Grant, LaLainia M Secreti, Wayne Triner, Ronald Moscati, August Leinhart, George L Ellis, Jawwad Khan.   

Abstract

The objective of the current study was to determine the classification accuracy of serum S100B and apolipoprotein (apoA-I) for mild traumatic brain injury (mTBI) and abnormal initial head computed tomography (CT) scan, and to identify ethnic, racial, age, and sex variation in classification accuracy. We performed a prospective, multi-centered study of 787 patients with mTBI who presented to the emergency department within 6 h of injury and 467 controls who presented to the outpatient laboratory for routine blood work. Serum was analyzed for S100B and apoA-I. The outcomes were disease status (mTBI or control) and initial head CT scan. At cutoff values defined by 90% of controls, the specificity for mTBI using S100B (0.899 [95% confidence interval (CI): 0.78-0.92]) was similar to that using apoA-I (0.902 [0.87-0.93]), and the sensitivity using S100B (0.252 [0.22-0.28]) was similar to that using apoA-I (0.249 [0.22-0.28]). The area under the receiver operating characteristic curve (AUC) for the combination of S100B and apoA-I (0.738, 95% CI: 0.71, 0.77), however, was significantly higher than the AUC for S100B alone (0.709, 95% CI: 0.68, 0.74, p=0.001) and higher than the AUC for apoA-I alone (0.645, 95% CI: 0.61, 0.68, p<0.0001). The AUC for prediction of abnormal initial head CT scan using S100B was 0.694 (95%CI: 0.62, 0.77) and not significant for apoA-I. At a S100B cutoff of <0.060 μg/L, the sensitivity for abnormal head CT was 98%, and 22.9% of CT scans could have been avoided. There was significant age and race-related variation in the accuracy of S100B for the diagnosis of mTBI. The combined use of serum S100B and apoA-I maximizes classification accuracy for mTBI, but only S100B is needed to classify abnormal head CT scan. Because of significant subgroup variation in classification accuracy, age and race need to be considered when using S100B to classify subjects for mTBI.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23758329      PMCID: PMC4047844          DOI: 10.1089/neu.2013.2853

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  23 in total

1.  Reference values for serum S-100B protein depend on the race of individuals.

Authors:  Ouardia Ben Abdesselam; Josette Vally; Camilo Adem; Marie-José Foglietti; Jean-Louis Beaudeux
Journal:  Clin Chem       Date:  2003-05       Impact factor: 8.327

2.  Apolipoprotein A-I and apolipoprotein SAA half-lives during acute inflammation and amyloidogenesis.

Authors:  C Tape; R Kisilevsky
Journal:  Biochim Biophys Acta       Date:  1990-04-17

3.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

Authors:  E R DeLong; D M DeLong; D L Clarke-Pearson
Journal:  Biometrics       Date:  1988-09       Impact factor: 2.571

4.  Rapid elimination of protein S-100B from serum after minor head trauma.

Authors:  Will Townend; Colin Dibble; Kamran Abid; Andy Vail; Roy Sherwood; Fiona Lecky
Journal:  J Neurotrauma       Date:  2006-02       Impact factor: 5.269

5.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

6.  The meaning and use of the area under a receiver operating characteristic (ROC) curve.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1982-04       Impact factor: 11.105

7.  High serum S100B levels for trauma patients without head injuries.

Authors:  R E Anderson; L O Hansson; O Nilsson; R Dijlai-Merzoug; G Settergren
Journal:  Neurosurgery       Date:  2001-06       Impact factor: 4.654

8.  S100 in mild traumatic brain injury.

Authors:  Catharina Nygren De Boussard; Pam Fredman; Anders Lundin; Kerstin Andersson; Gunnar Edman; Jörgen Borg
Journal:  Brain Inj       Date:  2004-07       Impact factor: 2.311

9.  Physician tolerance for uncertainty. Use of liver-spleen scans to detect metastases.

Authors:  R M Allman; E P Steinberg; J C Keruly; P E Dans
Journal:  JAMA       Date:  1985-07-12       Impact factor: 56.272

10.  Measurement of S-100B for risk classification of victims sustaining minor head injury--first pilot study in Brazil.

Authors:  Luiz F Poli-de-Figueiredo; Peter Biberthaler; Charles Simao Filho; Christopher Hauser; Wolf Mutschler; Marianne Jochum
Journal:  Clinics (Sao Paulo)       Date:  2006-03-10       Impact factor: 2.365

View more
  20 in total

1.  Correlation of Blood Biomarkers and Biomarker Panels with Traumatic Findings on Computed Tomography after Traumatic Brain Injury.

Authors:  Jussi P Posti; Riikka S K Takala; Linnéa Lagerstedt; Alex M Dickens; Iftakher Hossain; Mehrbod Mohammadian; Henna Ala-Seppälä; Janek Frantzén; Mark van Gils; Peter J Hutchinson; Ari J Katila; Henna-Riikka Maanpää; David K Menon; Virginia F Newcombe; Jussi Tallus; Kevin Hrusovsky; David H Wilson; Jessica Gill; Jean-Charles Sanchez; Olli Tenovuo; Henrik Zetterberg; Kaj Blennow
Journal:  J Neurotrauma       Date:  2019-04-05       Impact factor: 5.269

2.  Prospective Assessment of Acute Blood Markers of Brain Injury in Sport-Related Concussion.

Authors:  Timothy B Meier; Lindsay D Nelson; Daniel L Huber; Jeffrey J Bazarian; Ronald L Hayes; Michael A McCrea
Journal:  J Neurotrauma       Date:  2017-08-04       Impact factor: 5.269

3.  Modeling the Kinetics of Serum Glial Fibrillary Acidic Protein, Ubiquitin Carboxyl-Terminal Hydrolase-L1, and S100B Concentrations in Patients with Traumatic Brain Injury.

Authors:  Robert D Welch; Morgan Ellis; Lawrence M Lewis; Syed I Ayaz; Valerie H Mika; Scott Millis; Linda Papa
Journal:  J Neurotrauma       Date:  2017-02-27       Impact factor: 5.269

4.  Blood Biomarkers in Brain Injury Medicine.

Authors:  William R McBride; Caroline E Conlan; Nicole A Barylski; Amelie C Warneryd; Randel L Swanson
Journal:  Curr Phys Med Rehabil Rep       Date:  2022-02-26

Review 5.  S100B, GFAP, UCH-L1 and NSE as predictors of abnormalities on CT imaging following mild traumatic brain injury: a systematic review and meta-analysis of diagnostic test accuracy.

Authors:  Michael Amoo; Jack Henry; Philip J O'Halloran; Paul Brennan; Mohammed Ben Husien; Matthew Campbell; John Caird; Mohsen Javadpour; Gerard F Curley
Journal:  Neurosurg Rev       Date:  2021-10-28       Impact factor: 3.042

6.  Emergency Department Evaluation of Traumatic Brain Injury in the United States, 2009-2010.

Authors:  Frederick K Korley; Gabor D Kelen; Courtney M Jones; Ramon Diaz-Arrastia
Journal:  J Head Trauma Rehabil       Date:  2016 Nov/Dec       Impact factor: 2.710

7.  Testing a Multivariate Proteomic Panel for Traumatic Brain Injury Biomarker Discovery: A TRACK-TBI Pilot Study.

Authors:  J Russell Huie; Ramon Diaz-Arrastia; John K Yue; Marco D Sorani; Ava M Puccio; David O Okonkwo; Geoffrey T Manley; Adam R Ferguson
Journal:  J Neurotrauma       Date:  2018-09-27       Impact factor: 5.269

8.  Subject-specific increases in serum S-100B distinguish sports-related concussion from sports-related exertion.

Authors:  Karin Kiechle; Jeffrey J Bazarian; Kian Merchant-Borna; Veit Stoecklein; Eric Rozen; Brian Blyth; Jason H Huang; Samantha Dayawansa; Karl Kanz; Peter Biberthaler
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

9.  Validation of serum apolipoprotein A1 in rabies virus-infected mice as a biomarker for the preclinical diagnosis of rabies.

Authors:  Kentaro Yamada; Koji Kuribayashi; Naotaka Inomata; Kazuko Noguchi; Kazunori Kimitsuki; Catalino S Demetria; Nobuo Saito; Satoshi Inoue; Chun-Ho Park; Ryo Kaimori; Motoi Suzuki; Mariko Saito-Obata; Yasuhiko Kamiya; Daria L Manalo; Beatriz P Quiambao; Akira Nishizono
Journal:  Microbiol Immunol       Date:  2021-08-03       Impact factor: 2.962

10.  Validation of the Scandinavian guidelines for initial management of minimal, mild and moderate traumatic brain injury in adults.

Authors:  Linda Undén; Olga Calcagnile; Johan Undén; Peter Reinstrup; Jeff Bazarian
Journal:  BMC Med       Date:  2015-12-09       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.